2023
FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that Innovation Fund Denmark (Innovationsfonden)...
21 March, 2023
Minutes from Annual General Meeting in FluoGuide A/S
Copenhagen, Denmark, 21 March 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) held its annual general...
6 March, 2023
Notice of Annual General Meeting in FluoGuide A/S
The board of directors hereby convenes the Annual General Meeting of FluoGuide A/S, company registration (CVR) no. 39 29 64 38 (the...
27 February, 2023
FluoGuide updates on recruitment in phase IIb aggressive brain cancer trial with FG001
FluoGuide A/S (“FluoGuide” or the “Company”) provides an update on the clinical timelines for the ongoing clinical...
2 February, 2023
FluoGuide appoints Ole Larsen as CFO
FluoGuide A/S (“FluoGuide” or the “Company”) has appointed Ole Larsen as Chief Financial Officer (“CFO”)...
25 January, 2023
CFO acquired shares in FluoGuide
FluoGuide A/S (“FluoGuide” or the “Company”) announce that the CFO of FluoGuide, Henrik Hang, has acquired...
Copenhagen, Denmark, 9 January 2023 - FluoGuide A/S ("FluoGuide" or the "Company") is pleased to announce the positive...
2022
In Q3 2022, FluoGuide made important progress and received approvals from Danish authorities to initiate the clinical phase IIb trial...
Calendar &
upcoming reports
29 November 2023
8-10 January 2024
31 January 2024
Økonomisk Ugebrev Life Science Investor Conference
28 February 2024